| 1 |
Synthesis and Evaluation of Hydrogen Peroxide Sensitive Prodrugs of Methotrexate and Aminopterin for the Treatment of Rheumatoid Arthritis
Jorge Peiró Cadahía, Jon Bondebjerg, Christian A. Hansen et al. · Journal of Medicinal Chemistry
Open access |
31 Mar 2018 |
73 |
| 2 |
Regulation of vascular leak and recovery from ischemic injury by general and VE-cadherin–restricted miRNA antagonists of miR-27
Jennifer A. Young et al. · Blood
|
6 Sep 2013 |
71 |
| 3 |
A pooled analysis of randomized, controlled, phase 3 trials investigating the efficacy and safety of a novel, fixed dose calcipotriene and betamethasone dipropionate cream for the topical treatment of plaque psoriasis
Andreas Pinter, L. J. Green, Johan Selmer et al. · Journal of the European Academy of Dermatology and Venereology
Open access |
10 Oct 2021 |
45 |
| 4 |
Outpatient administration of naxitamab in combination with granulocyte‐macrophage colony‐stimulating factor in patients with refractory and/or relapsed high‐risk neuroblastoma: Management of adverse events
Jaume Mora, Gcf Chan, Daniel A. Morgenstern et al. · Cancer Reports
Open access |
17 May 2022 |
29 |
| 5 |
Polyaphron Dispersion Technology, A Novel Topical Formulation and Delivery System Combining Drug Penetration, Local Tolerability and Convenience of Application
Morten Præstegaard, D. Fraser Steele, Nigel Crutchley · Dermatology and Therapy
Open access |
Sep 2022 |
28 |
| 6 |
Methotrexate prodrugs sensitive to reactive oxygen species for the improved treatment of rheumatoid arthritis
Nikolaj S. Andersen, Jorge Peiró Cadahía, Viola Previtali et al. · European Journal of Medicinal Chemistry
Open access |
20 Jul 2018 |
27 |
| 7 |
Stenoparib, an Inhibitor of Cellular Poly(ADP-Ribose) Polymerase, Blocks Replication of the SARS-CoV-2 and HCoV-NL63 Human Coronaviruses In Vitro
Nathan E. Stone, Sierra A. Jaramillo, Ashley N. Jones et al. · mBio
Open access |
18 Jan 2021 |
24 |
| 8 |
A Signature of Exaggerated Adipose Tissue Dysfunction in Type 2 Diabetes Is Linked to Low Plasma Adiponectin and Increased Transcriptional Activation of Proteasomal Degradation in Muscle
Rugivan Sabaratnam, Vibe Skov, Søren Kildeberg Paulsen et al. · Cells
Open access |
23 Jun 2022 |
15 |
| 9 |
Calcipotriol and Betamethasone Dipropionate Cream Based on PAD Technology for the Treatment of Plaque Psoriasis: A Narrative Review
Tiago Torres, Jordi Galván, Nigel Crutchley et al. · Dermatology and Therapy
ReviewOpen access |
23 Sep 2023 |
14 |
| 10 |
Novel Oral Lichen Planus Symptom Severity Measure for assessing patients’ daily symptom experience
Laurie Beth Burke, Michael Thomas Brennan, Richeal Ní Ríordáin et al. · Oral Diseases
|
21 Apr 2019 |
13 |
| 11 |
Randomized Phase 3 trial demonstrating high efficacy, favourable safety and convenience of a novel calcipotriol and betamethasone dipropionate cream for the treatment of psoriasis
Andreas Pinter, Adam Reich, Monika Arenbergerová et al. · Journal of the European Academy of Dermatology and Venereology
Open access |
11 Jul 2023 |
12 |
| 12 |
Sensory properties analysis of a calcipotriol and betamethasone dipropionate cream vehicle formulated with an innovative PAD Technology for the treatment of plaque psoriasis on the skin and scalp
Nuria García, Pere Guiró, Jordi Galván et al. · Drugs in Context
Open access |
16 Mar 2023 |
12 |
| 13 |
Industrial ion-exchange chromatography development using discontinuous Galerkin methods coupled with forward sensitivity analysis
Kristian Meyer, Mikkel Søes Ibsen, Lisa Vetter-Joss et al. · Journal of Chromatography A
Open access |
23 Dec 2022 |
10 |
| 14 |
Enhanced Skin Deposition of Betamethasone Dipropionate from a Novel Formulation and Drug Delivery Technology
Zoe Diana Draelos, Matthew Michael Draelos, D. Fraser Steele et al. · Dermatology and Therapy
Open access |
23 Jun 2023 |
9 |
| 15 |
An anchored matching-adjusted indirect comparison of fixed-dose combination calcipotriol and betamethasone dipropionate (Cal/BDP) cream versus Cal/BDP foam for the treatment of psoriasis
Anthony Bewley, Erin T. Barker, Hannah Baker et al. · Journal of Dermatological Treatment
Open access |
29 Aug 2022 |
9 |
| 16 |
75P Efficacy and updated safety results from pivotal phase II trial 201 of naxitamab (Hu3F8): A humanized GD2-targeted immunotherapy for the treatment of refractory/relapsed (R/R) high-risk (HR) neuroblastoma (NB)
Jaume Mora, Gcf Chan, Daniel A. Morgenstern et al. · Annals of Oncology
Open access |
Dec 2020 |
9 |
| 17 |
Efficacy, quality of life, and treatment satisfaction: an indirect comparison of calcipotriol/betamethasone dipropionate cream versus foam for treatment of psoriasis
Adam Reich, Johan Selmer, Jordi Galván et al. · Current Medical Research and Opinion
Open access |
16 May 2022 |
8 |
| 18 |
Stenoparib, an inhibitor of cellular poly (ADP-ribose) polymerases (PARPs), blocks in vitro replication of SARS-CoV-2 variants
Katherine E. Zarn, Sierra A. Jaramillo, Anthony R. Zapata et al. · PLoS ONE
Open access |
14 Sep 2022 |
7 |
| 19 |
Validation of the Self-Reported Psoriasis Treatment Convenience Scale (PTCS)
Steven R. Feldman, Morten Præstegaard, Arne H. Andreasen et al. · Dermatology and Therapy
Open access |
14 Oct 2021 |
7 |
| 20 |
A novel, fixed‐dose calcipotriol and betamethasone dipropionate cream for the topical treatment of plaque psoriasis: Direct and indirect evidence from phase 3 trials discussed at the 30th EADV Congress 2021
Andreas Pinter, Linda Stein Gold, Adam Reich et al. · Journal of the European Academy of Dermatology and Venereology
Open access |
22 Dec 2022 |
6 |
| 21 |
891P Naxitamab treatment for relapsed or refractory high-risk neuroblastoma: Outcomes from the first prespecified analyses of the Pivotal 201 Trial
J. Mora, Misty D. Bear, Gavin S.W. Chan et al. · Annals of Oncology
Open access |
Sep 2022 |
6 |
| 22 |
963MO Naxitamab for the treatment of refractory/relapsed high-risk neuroblastoma (HR NB): Updated efficacy and safety data from the international, multicenter phase II trial 201
Jaume Mora, Misty D. Bear, Gcf Chan et al. · Annals of Oncology
Open access |
Sep 2021 |
6 |
| 23 |
74P Pivotal trial 201 data on outpatient administration of naxitamab (Hu3F8), a humanized GD2 targeted immunotherapy for the treatment of refractory/relapsed (R/R) high-risk (HR) neuroblastoma (NB)
Daniel A. Morgenstern, Jaume Mora, Gcf Chan et al. · Annals of Oncology
Open access |
Dec 2020 |
6 |
| 24 |
Paediatric Strategy Forum for medicinal product development of agents targeting GD2 ganglioside in children and adolescents with cancer
Steven G. DuBois et al. · European Journal of Cancer
Open access |
6 Nov 2025 |
5 |
| 25 |
Early Neutrophil Activation in Psoriatic Skin at Relapse Following Dead Sea Climatotherapy
Thomas Emmanuel, Hakim Ben Abdallah, Enrique Baez et al. · Experimental Dermatology
Open access |
Apr 2025 |
5 |
| 26 |
LBA3 Compartmental radioimmunotherapy (cRIT) 131I-OMBURTAMAB in patients with neuroblastoma (NB) central nervous system (CNS) and/or leptomeningeal (LM) metastases: Updated results from pivotal Trial 101
Ellen M. Basu, J. Mora, K. Streby et al. · Immuno-Oncology Technology
Open access |
Dec 2022 |
5 |
| 27 |
Oral lichen planus clinician reported outcome measure: Development, content validity, and further development
Michael Thomas Brennan, Richeal Ní Ríordáin, Leslie Long‐Simpson et al. · Oral Diseases
|
9 Nov 2022 |
5 |
| 28 |
380TiP A phase I/II dose-escalation and expansion cohort study of intracerebroventricular radioimmunotherapy using 177Lu-DTPA-omburtamab in pediatric and adolescent patients with recurrent or refractory medulloblastoma
Soumen Khatua, Marco Düring, Charlotte Lind et al. · Annals of Oncology
Open access |
Sep 2021 |
5 |
| 29 |
Topical cyclosporin A as a steroid‐sparing agent for ocular rosacea
Hon Shing Ong, Krishna V. Patel, John Dart et al. · Acta Ophthalmologica
Open access |
17 Jun 2016 |
5 |
| 30 |
HMB-002: a monovalent antibody that elevates circulating VWF and FVIII levels for treatment of von Willebrand disease
Mattias Häger, Minka Živkovic, Prafull S. Gandhi et al. · Blood Advances
Open access |
22 Jan 2026 |
4 |
| 31 |
A novel reuptake inhibitor, IP2015, induces erection by increasing central dopamine and peripheral nitric oxide release
Simón Comerma-Steffensen, Attila Kun, Judit Prat‐Duran et al. · British Journal of Pharmacology
Open access |
11 Apr 2024 |
4 |
| 32 |
A Tissue-Engineered Model of T-Cell–Mediated Oral Mucosal Inflammatory Disease
Asma El-Howati, Jake G. Edmans, Martin E. Santocildes‐Romero et al. · Journal of Investigative Dermatology
Open access |
3 Oct 2024 |
3 |
| 33 |
A novel calcipotriol and betamethasone dipropionate ( CAL / BDP ) PAD ‐cream demonstrates greater improvements in daily activities and personal relationships than CAL / BDP gel/ TS : A post‐hoc analysis of DLQI outcomes from two phase 3 placebo‐controlled randomized clinical trials in mild‐to‐moderate psoriasis
Bruno Halioua, G. Caillet, Charles TAIEB et al. · Journal of the European Academy of Dermatology and Venereology
Open access |
Nov 2023 |
3 |
| 34 |
Calcipotriene and Betamethasone Dipropionate PAD-Cream Demonstrates Greater Treatment Efficacy in Patients with Moderate-to-Severe Psoriasis Compared to Topical Suspension/Gel: A Subgroup Analysis of Two Phase 3 Studies
Linda Stein Gold, Andreas Pinter, April Wang Armstrong et al. · Dermatology and Therapy
Open access |
25 Jul 2023 |
3 |
| 35 |
The Epidemiology of Hospital-Treated Alopecia Areata in Denmark, 1995–2016
Sissel Brandt Toft Sørensen, Prethibha George, Oladayo Jagun et al. · Dermatology and Therapy
Open access |
Apr 2024 |
2 |
| 36 |
The Non-Human Primate in Safety Assessment of a Bifunctional Long-Acting Insulin Analogue
Vivi F. H. Jensen, Nikolai K. Jensen, Line H. Schefe et al. · International Journal of Toxicology
Open access |
17 Feb 2023 |
2 |
| 37 |
62MO Naxitamab pivotal clinical trial planned interim analysis of PFS and OS in patients with relapsed or refractory high-risk neuroblastoma
Jaume Mora, G.C. Chan, D.A. Morgenstern et al. · Immuno-Oncology Technology
Open access |
Dec 2022 |
2 |
| 38 |
DIPG-53. Long-term survival from a Phase 1 dose-escalation trial using convection-enhanced delivery (CED) of radioimmunotherapeutic124I-omburtamab for treatment of diffuse intrinsic pontine glioma (DIPG).
Mark M. Souweidane, Kim Kramer, Neeta Pandit-Tasker et al. · Neuro-Oncology
Open access |
Jun 2022 |
2 |
| 39 |
Calcipotriene And Betamethasone Dipropionate Cream Demonstrates High Treatment Success In Patients With Scalp Psoriasis
Andreas Pinter, Morten Præstegaard, Johan Selmer et al. · SKIN The Journal of Cutaneous Medicine
Open access |
4 Mar 2022 |
2 |
| 40 |
A Novel TREM2 Small Molecule Agonist MTX46943 Re‐Programs Human Microglia and Reduces Amyloid Pathology In Vivo
Manuela Polydoro, Ivana Geric, Jin Zheng et al. · Alzheimer s & Dementia
Open access |
Dec 2025 |
1 |
| 41 |
Meteorin Resolves Nociceptive Hypersensitivity by Reducing Connexin‐Mediated Coupling in Satellite Glial Cells
Lone Tjener Pallesen, A. Kirstein Pedersen, Ishwarya Sankaranarayanan et al. · Glia
|
8 Dec 2025 |
1 |
| 42 |
Systemic Targeted Therapies in Patients with Relapsed/Refractory Advanced Stage Cutaneous T-cell Lymphoma: A Real-world Single-centre Case Series
Signe Hedebo, Martin Bjerregård Pedersen, Lise M. Lindahl et al. · Acta Dermato Venereologica
Open access |
13 Mar 2025 |
1 |
| 43 |
Association of Conjunctival Cell HLA-DR Expression with the Severity of Signs and Symptoms of Dry Eye Disease at Baseline in the NORTHERN LIGHTS Phase 2 Trial
Eric J. Kuklinski, Neeta Singh Roy, Morten Præstegaard et al. · Current Eye Research
|
7 Mar 2025 |
1 |
| 44 |
129P Naxitamab efficacy in patients with refractory/relapsed high-risk neuroblastoma and bone metastases as assessed by Curie score
Brian H. Kushner, Jaume Mora, Gcf Chan et al. · Immuno-Oncology Technology
Open access |
Dec 2023 |
1 |
| 45 |
A novel drug specific mRNA biomarker predictor for selection of patients responding to dovitinib treatment of advanced renal cell carcinoma and other solid tumors
Steen Knudsen, Anker Hansen, Marie L. Foegh et al. · PLoS ONE
Open access |
30 Aug 2023 |
1 |
| 46 |
Postprandial Glycaemia, Insulinemia, and Lipidemia after 12 Weeks’ Cheese Consumption: An Exploratory Randomized Controlled Human Sub-Study
Louise Kjølbæk, Farinaz Raziani, Tine Tholstrup et al. · Dairy
Open access |
5 Jan 2023 |
1 |
| 47 |
Enhanced Skin Deposition of Betamethasone Dipropionate into the Skin of Human Volunteers from Calcipotriene/Betamethasone Dipropionate Cream Compared to Topical Suspension
Zoe Diane Draelos, Matthew Michael Draelos, Morten Præstegaard · SKIN The Journal of Cutaneous Medicine
Open access |
16 Nov 2022 |
1 |
| 48 |
The association between persistent cognitive difficulties and depression and functional outcomes in people with Major Depressive Disorder
Faith Matcham, Sara Katherine Simblett, Daniel Leightley et al.
PreprintOpen access |
11 Aug 2022 |
1 |
| 49 |
Dipropionate (Bdp) Cream (Cal 0.005%/Bdp 0.064% W/W) Improves Plaque Psoriasis At Week One In A Phase 3 Trial
George Han, Steven R. Feldman, Neal D Bhatia et al. · SKIN The Journal of Cutaneous Medicine
Open access |
7 Jul 2022 |
1 |
| 50 |
Why Biomarkers?
Penny A. Asbell · Eye & Contact Lens Science & Clinical Practice
|
Mar 2020 |
1 |